2021 to become a year of growth for Tauralp Group
Due to the Pandemic related export restrictions for pharmaceuticals last year has been under expectations regarding export to CIS countries.
We have succesfully focussed on our domestic markets and have increased our product portfolio.
The group has increased the revenues the 3rd year in a row as well as the profitability. To increase the value of our production facilities
Is permanently our focus and soon we will be able to produce medical devices and medicines in ampoules and vials.
We have already strengthened our logistic capabilities and have already started implementing two logistic hubs in 2021.
Our strategical move to enter UK and EU as new markets has reached important steps and pays out improving production load and revenues.
Management will strengthen our research & development and regulatory affairs department and sales structure this year.
Board of Tauralp Pharm Holding AG,
Rainer Alzinger, President, Romeo Ungureanu Vice President